| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2024 | 4 May 2024 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Notice pf Board Meeting Pursuant Regulation 29(2) SEBI (LODR) Regulation 2015. The Board Meeting is scheduled on 29th May2024 for the Approval of Financial Results for the Quarter and Year ended on 31-03-2024 at the registered office of the company at 3.30 pm . Kindly take the same on records . In accordance with Regulation 33 of the Listing Regulations: 1) The Board has discussed and approved Annual Audited Standalone Financial Results of the Company prepared as per Indian Accounting Standard (IND-AS) along with Auditors Report thereon and Statement of Assets and Liabilities, for the quarter and financial year ended 31st March 2024. 2) M/s. Vora & Associates, Chartered Accountants having Firm Regn. No. 111612W, Statutory Auditors have issued an Audit report with unmodified opinion(s) with respect to Audited Standalone Financial Results for the year ended March 31, 2024. 3) Declaration duly certified by the Chief Financial Officer of the Company to the effect that Auditors have submitted their Report with unmodified opinion. The Board Meeting commenced at 03:30 p.m. and concluded at 5:30 p.m. Read less.. (As Per BSE Announcement Dated on 29.05.2024) | ||
| Board Meeting | 31 Jan 2024 | 10 Jan 2024 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Intimation for the Board Meeting under Regulation 29(2) of SEBI(LODR) Regulation 2015 which will be scheduled on 31-01-2024 at 3.30 pm . We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 31st January, 2024 has, inter alia considered and approved Unaudited Financial Results (as per IND-AS) for the quarter and nine-months ended on 31st December, 2023. Enclosed herewith a copy of the same along with a copy of Limited Review Report dated 31st Jan, 2024 received from M/s. Vora & Associates, Chartered Accountants, Statutory Auditors of the Company with respect to Unaudited Financial Results for the quarter and nine-months ended on 31st December, 2023. (As Per BSE Announcement dated on 31.01.2024) | ||
| Board Meeting | 31 Oct 2023 | 14 Oct 2023 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Notice of Board Meeting pursuant to Regulation29(2) of SEBI(LODR) Regulation 2015 for the Quarter and Half Year Ended 30-9-2023 for publishing the Unaudited Financial Results. OUTCOME OF BOARD MEETING HELD ON 31-10-2023 UNDER REGULATION 30 AND 33 OF SEBI(LODR) REGULATION,2015 FOR THE QUARTER EDNED 30-9-2023. (As Per BSE Announcement dated on 31.10.2023) | ||
| Board Meeting | 31 Jul 2023 | 14 Jul 2023 |
| COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2023 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Monday 31st July 2023 at 03.30 P.M at the registered office of the Company at A 101 Pratik Ind Estate Mulund Goregaon Link Road Bhandup West Mumbai- 400078 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the quarter ended 30th June 2023. The outcome of the meeting held on 31-07-2023 for approving the unaudited Quarterly Results for the quarter ended 30-06-2023. and other related matter as mentioned in outcome of the meeting. The Meeting of Board of Directors was held on Monday, 31st July, 2023 at 03:30 p.m. The Board of Directors discussed and/or approved the following: 1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2023 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In this regard, the Statutory Auditors (Independent Auditors) have carried out Limited Review of the above results. Please find enclosed copy of unaudited financial results along with Limited Review Report for the quarter ended 30th June, 2023. (As Per BSE Announcement dated on 31.07.2023) As required under SEBI Regulation 33(3) of LODR, 2015, please find the attached Unaudited Financial Results of the Company as on 30-6-2023 approved in the Board meeting held on 31-7-2023. (As per BSE Announcement Dated on 09/08/2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
